248
Views
9
CrossRef citations to date
0
Altmetric
Letter

Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan–melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma

, , , , &
Pages 1415-1416 | Received 15 Aug 2011, Accepted 23 Dec 2011, Published online: 31 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ioanna Sakellari, Despoina Mallouri, Ioannis Batsis, Chrysa Apostolou, Varnavas Konstantinou, Eleni-Maria Abela, Vasiliki Douka, Anastasia Marvaki, Kyriakos Karypidis, Michalis Iskas, Panayiotis Baliakas, Panayotis Kaloyannidis, Evangelia Yannaki, Damianos Sotiropoulos, Giorgos Kouvatseas, Christos Smias & Achilles Anagnostopoulos. (2015) Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas. Leukemia & Lymphoma 56:11, pages 3071-3081.
Read now

Articles from other publishers (8)

Tarik Hadid, Ayad Al-Katib, Jose Binongo, Gina M. Berteotti, Salman Fazal, James M. Rossetti & John Lister. (2023) Palifermin Compared to Supersaturated Calcium Phosphate Rinse in Prevention of Severe Oral Mucositis after Stem Cell Transplantation in Patients Receiving Radiotherapy-Based Myeloablative Conditioning. Hemato 4:1, pages 58-67.
Crossref
John Coutsouvelis, Carmela Corallo, Andrew Spencer, Sharon Avery, Michael Dooley & Carl M Kirkpatrick. (2022) A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy. Critical Reviews in Oncology/Hematology 172, pages 103606.
Crossref
Annette Brant Isozaki & Jeannine M. Brant. (2022) Clinical Updates in Mucositis-Related Symptom Management. Seminars in Oncology Nursing 38:1, pages 151252.
Crossref
Solmaz Sadeghi, Hourieh Kalhor, Mohammad Panahi, Hoda Abolhasani, Bahareh Rahimi, Reyhaneh Kalhor, Amirmehdi Mehrabi, Mahsa Vahdatinia & Hamzeh Rahimi. (2021) Keratinocyte growth factor in focus: A comprehensive review from structural and functional aspects to therapeutic applications of palifermin. International Journal of Biological Macromolecules 191, pages 1175-1190.
Crossref
Jennifer A. Novak & Arya Amini. 2021. Oncologic Emergency Medicine. Oncologic Emergency Medicine 679 689 .
Pengfei Zhang, Jing Liu, Bohui Xiong, Cong Zhang, Beining Kang, Yishan Gao, Zengkuan Li, Wei Ge, Shunfeng Cheng, Yanan Hao, Wei Shen, Shuai Yu, Liang Chen, Xiangfang Tang, Yong Zhao & Hongfu Zhang. (2020) Microbiota from alginate oligosaccharide-dosed mice successfully mitigated small intestinal mucositis. Microbiome 8:1.
Crossref
Yong Zhao, Yanni Feng, Ming Liu, Liang Chen, Qingshi Meng, Xiangfang Tang, Shukun Wang, Lei Liu, Lan Li, Wei Shen & Hongfu Zhang. (2020) Single-cell RNA sequencing analysis reveals alginate oligosaccharides preventing chemotherapy-induced mucositis. Mucosal Immunology 13:3, pages 437-448.
Crossref
Joanne M. Bowen, Rachel J. Gibson, Janet K. Coller, Nicole Blijlevens, Paolo Bossi, Noor Al-Dasooqi, Emma H. Bateman, Karen Chiang, Charlotte de Mooij, Bronwen Mayo, Andrea M. Stringer, Wim Tissing, Hannah R. Wardill, Ysabella Z. A. van Sebille, Vinisha Ranna, Anusha Vaddi, Dorothy MK. Keefe, Rajesh V. Lalla, Karis Kin Fong Cheng & Sharon Elad. (2019) Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines. Supportive Care in Cancer 27:10, pages 4011-4022.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.